240 likes | 545 Vues
PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti. 18 F-DOPA PET. Somatostatin Receptor PET. 18 F-DOPA PET. CLINICAL APPLICATIONS. NEUROLOGY: Movement disorders (Parkinson Disease). ONCOLOGY: Neuroendocrine tumors Pheochromocytoma Neuroblastoma (?). F-DOPA. FDG.
E N D
PET E TUMORI NEUROENDOCRINI: NUOVI TRACCIANTI Stefano Fanti
18F-DOPA PET Somatostatin Receptor PET
CLINICAL APPLICATIONS NEUROLOGY: Movement disorders (Parkinson Disease) ONCOLOGY: Neuroendocrine tumors Pheochromocytoma Neuroblastoma (?)
F-DOPA FDG M, 59yo. Metastatic carcinoid.
F 45yo: staging of metastatic carcinoid. Several bone lesions
Male,62yo. Secondary lesions within the liver. Unknown primary.
Female,30yo. Diffuse secondary lesions within the liver. Unknown primary.
Male,52yo. Secondary lesions within the liver. Unknown primary.